Discovery and development of N-cadherin antagonists

Cell and Tissue Research

Volumn 348, Issue 2, 2012, Pages 309-313

  Blaschuk, Orest W ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

ADH 1; Angiogenesis; Cancer; Endothelial cells; N cadherin

Indexed keywords

4 (1,2,3,4 THIATRIAZOL 5 YLAMINO)PHENOL; ADH 1 PEPTIDE; ALANINE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DISULFIDE LINKED CYCLIC PEPTIDE DERIVATIVE; MELPHALAN; MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE ANTAGONIST; NERVE CELL ADHESION MOLECULE ANTIBODY; PEPTIDE DERIVATIVE; SYNTHETIC PEPTIDE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADVANCED CANCER; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; BIOLOGICAL ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL ADHESION; CELL JUNCTION; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; MELANOMA; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW;

AMINO ACID SEQUENCE; CADHERINS; HUMANS; PEPTIDES;

EID: 84862767410     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1320-5     Document Type: Review

References (39)

1. Augustine CK, Yoshimoto Y, Gupt M, Zipfel PA, Selim MA, Febbo P, Pendergast AM, Peters WP, Tyler DS (2008) Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 68:3777-3784
2. Baluk P, Hashimyza H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15:102-111 (Pubitemid 40127638)
3. Beasley GM, McMahon N, Sanders G, Augustine CK, Selim MA, Peterson B, Norris R, Peters WP, Ross MI, Tyler DS (2009) A Phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer 115:4766-4774
4. Blaschuk OW, Devemy E (2009) Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 625:195-198
5. Blaschuk OW, Gour B (2000) Compounds and methods for modulating cell adhesion. United States Patent Number 6,031,072
6. Blaschuk OW, Sullivan R, David S, Pouliot Y (1990) Identification of a cadherin cell adhesion recognition sequence. Develop Biol 139:227-229
7. Blaschuk OW, Gour BJ, Farookhi R, Anmar A (2003) Compounds and methods for modulating endothelial cell adhesion. United States Patent Number 6,610,821
8. Bryan RT, Tselepis T (2010) Cadherin switching and bladder cancer. J Urol 184:423-431
9. Devemy E, Blaschuk OW (2008) Identification of a novel N-cadherin antagonist. Peptides 29:1853-1861
10. Doherty P, Rowett LH, Moore SE, Mann SE, Walsh FS (1991) Neurite outgrowth in response to transfected N-CAM and N-cadherin reveals fundamental differences in neuronal responsiveness to CAMs. Neuron 6:247-258
11. Erez N, Zamir E, Gour BJ, Blaschuk OW, Geiger B (2004) Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling. Exp Cell Res 294:366-378 (Pubitemid 38326737)
12. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273-286 (Pubitemid 46505878)
13. Franke WW (2009) Discovering the molecular components of intercellular junctions-a historical view. Cold Spring Harb Perspect Biol 1:a003061
14. Gaengel K, Genovè G, Armulik A, Betsholtz C (2009) Endothelial- mural cell signalling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29:630-638
15. Gerhardt H, Wolburg H, Redies C (2000) N-cadherin mediates pericyte-endothelial interaction during brain angiogenesis in the chicken. Dev Dyn 218:472-479 (Pubitemid 30461783)
16. Gour BJ, Blaschuk OW, Ali A, Ni F, Chen Z, Michaud SD, Wang S, Hu Z (2007) Peptidomimetic modulators of cell adhesion. United States Patent Number 7,268,115
17. Hansen SM, Berezin V, Bock E (2008) Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell Mol Life Sci 65:3809-3821
18. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790
19. Hazan RB, Qiao R, Keren R, Badano I, Suyama K (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155-163 (Pubitemid 38594801)
20. Hulpiau P, van Roy F (2008) Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol 41:349-369
21. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV, Molkentin JD, Radice GL (2005) Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 96:346-354 (Pubitemid 40279909)
22. Lyon CA, Koutsouki E, Aguilera CM, Blaschuk OW, George SJ (2010) Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis. J Vasc Surg 52:1301-1309
23. Mege RM, Goudou D, Diaz C, Nicolet M, Garcia L, Geraud G, Rieger F (1992) N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J Cell Sci 103:897-906 (Pubitemid 23042233)
24. Naumov GN, Folkman J, Straume O, Akslen LA (2008) Tumor- vascular interactions and tumor dormancy. APMIS 116:569-585
25. Paik J-H, Skoura A, Chae S-S, Cowan AE, Han DK, Proia RL, Hla T (2004) Shingosine1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 18:2392-2403 (Pubitemid 39304686)
26. Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D, Zanaboni F, Fasolo A, Capri G, Miani M, Peters WP, Gianni L (2009) Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol 20:741-745
27. Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C, Wistuba II (2009) Epithelial-tomesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 22:668-678
28. Salomon D, Ayalon O, Patel R, King P, Hynes RO, Geiger B (1992) Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 102:7-17
29. Sanchez-Heras E, Howell FV, Williams G, Doherty P (2006) The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule. J Biol Chem 281:35208-35216 (Pubitemid 46036559)
30. Shapiro L, Weis WI (2009) Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 1:a003053
31. Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, HollingsworthMA, Wheelock MJ, Johnson KR (2008) ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer 122:71-77 (Pubitemid 350209980)
32. Takeichi M (1988) The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development 102:639-655
33. Tamura K, Shan W, Hendrickson W, Colman D, Shapiro L (1998) Structure-function analysis of cell adhesion by neural (N-) cadherin. Neuron 20:1153-1163 (Pubitemid 28293132)
34. Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nature Med 16:1414-1420
35. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA (2000) Cadherin switching in human prostate cancer progression. Cancer Res 60:3650-3654 (Pubitemid 30482189)
36. Troyanovsky RB, Laur O, Troyanovsky SM (2007) Stable and unstable cadherin dimers: mechanisms of formation and roles in cell adhesion. Mol Biol Cell 18:4343-4352 (Pubitemid 350060163)
37. Vendome J, Posy S, Jin X, Bahna F, Ahlsen G, Shapiro L, Honig B (2011) Molecular design principles underlying β-strand swapping in the adhesive dimerization of cadherins. Nat Struc Mol Biol 18:693-700
38. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR (2008) Cadherin switching. J Cell Sci 121:727-735 (Pubitemid 351578108)
39. Wilby MJ, Muir EM, Fok-Seang J, Gour BJ, Blaschuk OW, Fawcett J (1999) N-cadherin inhibits Schwann cell migration on astrocytes. Mol Cell Neurosci 14:66-84 (Pubitemid 29372856)